Harmony Biosciences Holdings, Inc.

HRMY | NASDAQ | 0 Sledující

$34.50

1.32%

$0.45

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	714,734 +22.80%	582,022 +32.93%	437,855 +43.35%	305,440 -
Cost of revenue	156,815 +29.35%	121,236 +45.23%	83,481 +50.37%	55,518 -
Gross profit	557,919 +21.08%	460,786 +30.03%	354,374 +41.79%	249,922 -
Operating expense	367,093 +36.59%	268,756 +14.76%	234,188 +44.21%	162,394 -
Operating income	190,826 -0.63%	192,030 +59.78%	120,186 +74.93%	68,704 -
Pretax Income	191,804 +10.62%	173,396 +65.63%	104,686 +179.70%	37,428 -
Tax Provision	46,311 +3.97%	44,543 +158.01%	-76,782 -2,812.19%	2,831 -
Net income	145,493 +12.91%	128,853 -28.99%	181,468 +424.52%	34,597 -
EPS	2.56 +17.97%	2.17 -29.32%	3.07 +411.67%	0.6 -
Diluted EPS	2.51 +17.84%	2.13 -28.28%	2.97 +412.07%	0.58 -
Average Shares	56,885 -4.35%	59,470 +0.50%	59,173 +2.85%	57,532 -
Diluted Average Shares	57,870 -4.15%	60,372 -1.19%	61,097 +3.20%	59,205 -
EBIT	209,300 +6.16%	197,153 +64.04%	120,186 +95.04%	61,622 -
EBITDA	233,412 +5.37%	221,512 +54.29%	143,571 +34.98%	106,368 -

Soubory cookie používáme ke zlepšení prohlížení na webu.